Irradiation



Indications and Reactions:

Role Indications Reactions
Secondary
Bone Marrow Transplant 22.5%
Stem Cell Transplant 22.5%
Cord Blood Transplant Therapy 14.7%
Bone Marrow Conditioning Regimen 7.0%
Graft Versus Host Disease 7.0%
Acute Lymphocytic Leukaemia 5.4%
Chloroma 4.7%
Lung Adenocarcinoma 4.7%
Prophylaxis Against Graft Versus Host Disease 4.7%
Immunosuppression 1.6%
Leiomyosarcoma 1.6%
Anaemia 0.8%
Hypothyroidism 0.8%
Non-hodgkin's Lymphoma 0.8%
Product Used For Unknown Indication 0.8%
Pyrexia 0.8%
Somnolence 12.9%
Venoocclusive Liver Disease 9.7%
White Blood Cell Count Decreased 9.7%
Hepatic Steatosis 6.5%
Pneumonia 6.5%
Radiation Pneumonitis 6.5%
Visual Field Defect 6.5%
Acute Myeloid Leukaemia 3.2%
Cardiac Disorder 3.2%
Drug Toxicity 3.2%
Febrile Neutropenia 3.2%
Nephropathy Toxic 3.2%
Obstructive Airways Disorder 3.2%
Pleural Effusion 3.2%
Protein Urine 3.2%
Radiation Injury 3.2%
Respiratory Failure 3.2%
Sputum Abnormal 3.2%
Thrombocytopenia 3.2%
Thrombotic Microangiopathy 3.2%
Concomitant
Stem Cell Transplant 27.9%
Cord Blood Transplant Therapy 22.7%
Prophylaxis Against Graft Versus Host Disease 17.5%
Bone Marrow Transplant 13.1%
Graft Versus Host Disease 3.6%
Aplastic Anaemia 2.7%
Prophylaxis 2.2%
Allogenic Bone Marrow Transplantation Therapy 2.1%
Bone Marrow Conditioning Regimen 1.2%
Premedication 1.0%
Acute Lymphocytic Leukaemia 1.0%
Hodgkin's Disease 1.0%
Unrelated Donor Bone Marrow Transplantation Therapy 0.8%
Lymphoma 0.7%
Desmoplastic Small Round Cell Tumour 0.6%
Renal Transplant 0.6%
Hiv Infection 0.4%
Acute Graft Versus Host Disease 0.3%
Acute Graft Versus Host Disease In Skin 0.3%
Chronic Graft Versus Host Disease 0.3%
Thrombotic Microangiopathy 15.9%
Toxic Encephalopathy 8.3%
Acute Graft Versus Host Disease 6.1%
Acute Graft Versus Host Disease In Skin 6.1%
Pyrexia 6.1%
Weight Increased 6.1%
Rash 4.5%
Swollen Tongue 4.5%
Thrombocytopenia 4.5%
Visual Acuity Reduced 4.5%
Chronic Graft Versus Host Disease 3.8%
Renal Impairment 3.8%
Venoocclusive Liver Disease 3.8%
Vomiting 3.8%
Malignant Neoplasm Progression 3.0%
Neuroblastoma Recurrent 3.0%
Sepsis 3.0%
Staphylococcal Sepsis 3.0%
Stem Cell Transplant 3.0%
Transplant Rejection 3.0%
Interacting
Breast Cancer 100.0%
Uterine Disorder 100.0%